Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00518
|
|||||
| Drug Name |
Pioglitazone
|
|||||
| Synonyms |
(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione; (+/-)-5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione; (+/-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione; 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-(9CI); 5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione; 5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione; 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione; 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione; 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione; 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione; 5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine-2,4-dione; 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione; AD 4833; AD-4833; Actos; Actos (TN); Actost; Duetact; Glustin; Glustin (TN); HS-0047; Pioglitazona; Pioglitazona [INN-Spanish]; Pioglitazone (INN); Pioglitazone [BAN:INN]; Pioglitazone [INN:BAN]; Pioglitazonum; Pioglitazonum [INN-Latin]; U 72107; U 72107A; U-72107; U72,107A; Zactos; Zactos (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Hypoglycemic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C19H20N2O3S
|
|||||
| Canonical SMILES |
CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
|
|||||
| InChI |
InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)
|
|||||
| InChIKey |
HYAFETHFCAUJAY-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 111025-46-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 356.4 | Topological Polar Surface Area | 93.6 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
3.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103181943
, 103853946
, 104307547
, 10852019
, 11364517
, 11367079
, 11369641
, 11372042
, 11374757
, 11377803
, 11485633
, 11489495
, 11490817
, 11492944
, 11495437
, 117695425
, 118855323
, 124892398
, 14828061
, 22395182
, 26756476
, 29223911
, 46507136
, 47359443
, 47805056
, 48403962
, 49836649
, 50052255
, 50111371
, 50830677
, 53790062
, 5514443
, 56311254
, 56312043
, 56313970
, 56313978
, 56314560
, 57288465
, 57288698
, 57288809
, 57322474
, 7980327
, 81040922
, 8152965
, 841973
, 85789264
, 92308830
, 92712064
, 96025064
, 9877
|
|||||
| ChEBI ID |
ChEBI:8228
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.